MAPK8 and acute lymphoblastic leukemia: These results are consistent with those obtained in GC-resistant T-ALL cell lines showing that a low dose of anisomycin, an activator of JNK and p38 MAPK, effectively sensitizes them to dexamethasone-induced cell cycle arrest and apoptosis [107].